title: Bridging the gap between adult and paediatric outcomes in HIV-1 vertically infected children: a single-centre comparison with adult data.
abstract: Prognosis of HIV-1 infection dramatically improved during the last decade. Meanwhile, treatment-induced virological success has always been different in adult and children patients.
  
  
  OBJECTIVE
  To compare 10 years of follow up in HIV-1 vertically infected children and adult patients.
  
  
  METHODS
  Monocentric retrospective longitudinal analysis of vertically HIV-1-infected children and adult patients followed in the Nice University Hospital between 1999 and 2008. Immunological, virological and antiretroviral treatment data were recorded.
  
  
  RESULTS
  Forty children and 1752 adult patients were included. Between 1996 and 2008, the percentage of children receiving HAART increased from 3.2% to 91%. Mean CD4% in the paediatric group remained stable between 29 +/- 8.1% in 1998 and 30 +/- 9.4% in 2008. Mean adult CD4-cell count significantly increased from 410 in 1998 to 556 cells/mL in 2008. Logistic regression analysis showed that the children-to-adult difference for indetectability (HIV PCR-RNA below 400 copies/mL) was significant (p < 0.0001) with an odds ratio of 0.61 (CI(95th): 0.52-0.72). Year-to-patient interaction was also significant with a decreasing divergence over time (p: 0.038).
  
  
  CONCLUSIONS
  Nowadays as in adult patients, the control of HIV-1 replication is achieved in nearly eight of 10 children and the percentage of patients with severe immunodeficiency dramatically decreased compared with the mid 1990s.
authors.affiliation: Service de Pédiatrie, Hôpital de l'Archet II, Centre Hospitalier Universitaire de Nice, Nice Cedex, France. monpoux.f@chu-nice.fr
authors.forename: F
authors.initials: F
authors.lastname: Monpoux
authors.forename: P
authors.initials: P
authors.lastname: Puglièse
authors.forename: F
authors.initials: F
authors.lastname: Berthier
authors.forename: J
authors.initials: J
authors.lastname: Cottalorda
authors.forename: C
authors.initials: C
authors.lastname: Pradier
mesh_terms: D000328:Adult; D000367:Age Factors; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count / Q000706:statistics & numerical data; D016009:Chi-Square Distribution; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D005602:France; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000635:transmission / Q000821:virology; D015497:HIV-1 / Q000276:immunology; D006785:Hospitals, University; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D016015:Logistic Models; D008297:Male; D017063:Outcome Assessment, Health Care; D010372:Pediatrics; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood; D012189:Retrospective Studies; D019562:Viral Load / Q000706:statistics & numerical data
chemical_list: D012367:RNA, Viral
references.citation: Clin Infect Dis. 2008 Feb 15;46(4):507-15
references.pmid: 18199042
references.citation: Br J Clin Pharmacol. 2007 Jul;64(1):105-9
references.pmid: 17324223
references.citation: AIDS. 2008 Jul 31;22(12):1463-73
references.pmid: 18614870
references.citation: AIDS. 2007 Jul 31;21(12):1607-15
references.pmid: 17630556
references.citation: Med Mal Infect. 2008 Jun;38(6):299-308
references.pmid: 18395383
references.citation: JAMA. 2000 Jul 12;284(2):190-7
references.pmid: 10889592
references.citation: AIDS Patient Care STDS. 2009 Mar;23(3):159-66
references.pmid: 19866533
references.citation: Clin Infect Dis. 2007 Oct 1;45(7):918-24
references.pmid: 17806062
references.citation: AIDS. 2004 Sep 24;18(14):1915-24
references.pmid: 15353977
references.citation: Lancet. 2008 Jul 26;372(9635):293-9
references.pmid: 18657708
references.citation: AIDS. 2008 Jan 11;22(2):249-55
references.pmid: 18097227